Biological Drug Targets

A drug target is a molecule within the body, normally a protein that is naturally associated with a specific disease process which may be addressed by a drug to deliver a desired therapeutic effect. Biological target identification and approval are the most vital steps in developing a novel drug. Drug target validation includes demonstrating that DNA, RNA, or a protein molecule is specifically included in a disease process and can be a suitable target for improvement of a novel therapeutic drug. The most common drug targets of currently marketed drugs are proteins and nucleic acids.

  • Pharmacophore
  • Pharmaceutical drugs
  • Chemical libraries
  • Drug-receptor interaction
  • Drug target identification
  • Molecular medicine

Related Conference of Biological Drug Targets

April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 14-15, 2025

35th Annual European Pharma Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Paris, France
August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Aix-en-Provence, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands

Biological Drug Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in